Allegheny Financial Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Allegheny Financial Group's PFE Position: Q2 2026 in Review
Allegheny Financial Group increased its Pfizer (PFE) stake by 3% in Q2 2026, buying an estimated $35.4K and bringing the position to 46,701 shares worth $1.12M. The position accounts for 0.12% of the portfolio, ranked #101.
Allegheny Financial Group first reported a position in PFE in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.74M in Q4 2021. 2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Allegheny Financial Group held 46,701 shares of Pfizer worth $1.12M as of Q2 2026.
- Allegheny Financial Group bought 1,354 Pfizer shares in Q2 2026, an estimated $35.4K.
- Pfizer made up 0.12% of Allegheny Financial Group's portfolio in Q2 2026, its #101 holding.
- Allegheny Financial Group first reported a position in Pfizer in Q4 2020 and has held it in 22 quarters since.
- Allegheny Financial Group's Pfizer position peaked at $1.74M in Q4 2021.
- 2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Allegheny Financial Group's 13F filing for Q2 2026, filed 22 Jul 2026.